By MATTHEW PERRONE and LAURAN NEERGAARD. WASHINGTON (AP) — U.S. regulators are strictly limiting who can receive Johnson & Johnson's COVID-19 vaccine due to a rare but serious risk of blood clots.
So then there is an acknowledged problem with the vaxxx's. How wonderful they tell us now. Has been suspected for some time. Well, we were all the clinical trials and knew it all the time.
I am a dissident journalist, whose work has been published in dozens of daily newspapers, magazines, and journals in English, German, and Swedish, under my own name and many pseudonyms. While living in internal exile in New York, where I am whitelisted, I maintain NSU/The Wyatt Earp Journalism Bureau and some eight other blogs (some are distinctive but occasional venues, while others are mirrors), and also write for stout-hearted men such as Peter Brimelow and Jared Taylor. Please hit the “Donate” button on your way out. Thanks, in advance.
Follow my tweets at @NicholasStix.
2 comments:
J&J:Jab and Jenocide.
--GRA
So then there is an acknowledged problem with the vaxxx's. How wonderful they tell us now. Has been suspected for some time. Well, we were all the clinical trials and knew it all the time.
Post a Comment